Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.

Maike Henningsen; Kerstin Kress; Jan Felix Kersten; Ergün Kilic; Matthias Choschzick; Hilke Zander; Volkmar Müller; Sven Mahner; Fritz Jänicke; Linn Wölber; Karin Milde-Langosch

doi:10.1186/1471-2407-12-140

Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.

Maike Henningsen
Kerstin Kress
Jan Felix Kersten
Ergün Kilic
Matthias Choschzick
Hilke Zander
Volkmar Müller
Sven Mahner
Fritz Jänicke
Linn Wölber
Karin Milde-Langosch

Related Research units

Department of Gynecology
Institute of Medical Biometry and Epidemiology
Institute of Pathology
Department of General, Visceral and Thoracic Surgery

Abstract

An altered expression of the activated leukocyte cell adhesion molecule (ALCAM) is associated with cancer progression in various cancer types. In some cancers ALCAM has a prognostic value or is predictive for the benefit of therapeutic interventions. To date there are no data on the role of ALCAM in cervical cancer available.

Bibliographical data

Original language	English
ISSN	1471-2407
DOIs	https://doi.org/10.1186/1471-2407-12-140
Publication status	Published - 2012

pubmed	22475274